期刊文献+

骨桥蛋白靶向干扰RNA对体外人脐静脉内皮细胞增殖和凋亡的影响

暂未订购
导出
摘要 目的:观测骨桥蛋白靶向干扰RNA对体外人脐静脉内皮细胞(HUVEC)增殖和凋亡的影响。方法:体外化学合成骨桥蛋白序列特异性的短发夹RNA(shRNA)质粒载体与阳离子脂质体结合介导转染HUVEC,同时设计空白载体转染对照和空白对照,用MTT法等方法检测各组HUVEC生长增殖情况的变化,并用流式细胞术检测细胞凋亡情况。结果:OPN-shRNA载体转染HUVEC后明显抑制细胞增殖(P<0.05)和使细胞分裂周期出现阻滞,凋亡二倍体数量增加,凋亡率显著升高(P<0.05)。结论:骨桥蛋白靶向干扰RNA在体外能够抑制HUVEC的增殖,升高细胞凋亡率。
出处 《实用医学杂志》 CAS 北大核心 2012年第15期2499-2501,共3页 The Journal of Practical Medicine
基金 广东省科技计划资助项目(编号:2010B031600007)
  • 相关文献

参考文献8

  • 1Fonsatti E, Altomonte M, Nieotra M R, et al. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels [J]. Oncogene, 2003,22(42) :6557- 6563.
  • 2Guerrero Esteo M, Sanchez Eisner T, Letamendia A, et al. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II [J]. Biol Chem, 2002,277 (32) : 29197-29209.
  • 3温雯,林帆,刘坚初,范少锋,李坤平.骨桥蛋白表达与肝癌侵袭转移关系的研究[J].国际医药卫生导报,2011,17(7):769-771. 被引量:1
  • 4Teunis M A, Kavelaasr A, Voest E, et al. Redueed tumor gorwth, experimental metastasisormation, and angiogenesis inrats with a hyperreactive dopminergic system [J]. FASEB J, 2002,16(7) : 1465-1467.
  • 5Kuhn H, Riedel A, Eichler W, et al. Influence of adenoviral vector on expression of angiogenesis regulating factors in non- small cell lung cancer lines [J]. Cancer Immunol Immunother, 2002,51 (8) : 461-466.
  • 6Takahashi F, Akatagawa S, Fukumoto H, et al. Osteopontin induces angiogenesis of murine neuroblastoma ceils in mice [J]. Int J Cancer, 2002,98(5):707-712.
  • 7Philip S, Kundu G C. Osteopontin induces nuclear factorkappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways [ J ]. J Biol Chem, 2003,278 (16) : 14487-14497.
  • 8Rangaswami H, Bulbule A, Kundu G C. Nuclear factor- inducing kinase plays a crucial role in osteopontin-induced MAPK/I kappa B alpha kinase-dependent nuclear factor kappa B-mediated promatrix metalloproteinase-9 activation [J]. J Biol Chem, 2004,279(37)38921-38935.

二级参考文献11

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics[J].CA Cancer J Clin,2006,56:106-130.
  • 2Budhu AS,Zipser B,Forgues M,et al.The molecular signature of metastases of human hepatoccllularcarcinoma[J].Oncology,2005,69 (11):23-27.
  • 3Pan HW,Qu YH,Peng SY,et al.Overexpression of osteopotin is associated with intrahepatic matastasis,early recurrence,and poorer prognosis of surgically resected hepatocellular careinoma[J].Cancer,2003,98 (1):119-127.
  • 4Coppola D,Szabo M,Boulware D,et al.Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies[J].Clin Cancer Res,2004,10(1):184-190.
  • 5Gotoh M,Sakamoto M,Kanetaka K,et al.Overexpression of osteopontin in hepatocellular carcinoma[J].Pathol Int,2002,52:19-24.
  • 6Celetti LX,Testa D,Staibano S,et al.Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell cariomas and enhances carcinoma cell proliferation and invasiveness[J].Clin Cancer Res 2005,11(22):8019-8027.
  • 7Wallach RC,Seidman JD,O' Regan A,et al.Osteopontin as a Biomarker for Ovarian Cancer[J]JAMA,2002,287(24):3208-3209.
  • 8Desilva Rudland S,Martin L,Roshanlall C,et al.Assoc iation of S00A4 and Osteopontin with Spccific Prognostic Factors and Suevival of Patients with Minimally Invasive Breat Cancer[J].Clin Cancer Res,2006,12(4):1192-2000.
  • 9Robison B,W.S,Lake R.A.Medical progress Advances in malignant mesothelioma.[J].N Engl J Med,2005,353:1597-1603.
  • 10Wai PY,Kuo PC,The role of Osteopontin in tumor metastasis[J].J Sueg Res,2004,121 (2):228-241.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部